Emily Hajjar

5.0k citations
29 papers · 3.5k indexed · 2 hit papers · h-index 16
Topics
Pharmaceutical Practices and Patient Outcomes (20 papers)Health Systems, Economic Evaluations, Quality of Life (12 papers)Medication Adherence and Compliance (6 papers)
Partner nations
United States

In The Last Decade

Emily Hajjar

28 papers receiving 3.4k citations

Hit Papers

Clinical consequences of polypharmacy in elderly2007202620132019201320074008001.2k

Peers

Emily Hajjar
Comparison fields: 5 of 127
  • Geriatrics and Gerontology 2.4k
  • Economics and Econometrics 1.2k
  • Family Practice 751
  • Cardiology and Cardiovascular Medicine 682
  • Pediatrics, Perinatology and Child Health 449
Replace Sepehr Shakib with:
Sepehr Shakib Australia
Allen Huang Canada
Lisa Kalisch Ellett Australia
Marie‐Laure Laroche France
Kristina Johnell Sweden
Alessandro Nobili Italy
Christine M. Ruby United States
Amy Page Australia
Emily Reeve Australia
Daniela Fialová Czechia
Emily Hajjar relative to Sepehr Shakib Australia Sepehr Shakib's profile →
Citations per field
00.5×1.5×
Sepehr Shakib · 1×
Citations per year

Countries citing papers authored by Emily Hajjar

Since Specialization
Citations

This map shows the geographic impact of Emily Hajjar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Hajjar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Hajjar more than expected).

Fields of papers citing papers by Emily Hajjar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Hajjar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Hajjar. The network helps show where Emily Hajjar may publish in the future.

Co-authorship network of co-authors of Emily Hajjar

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Hajjar. A scholar is included among the top collaborators of Emily Hajjar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Hajjar. Emily Hajjar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 6
4 8
5
Deprescribing: A simple method for reducing polypharmacy.
27
6 26
7 8
8 195
9 4
10 34
11 15
12 3
13 227
14 56
15
Polypharmacy in elderly patientsbreakdown →
899
16 96
17 170
18 171
19 136
20 51

About Emily Hajjar

Emily Hajjar is a scholar working on Geriatrics and Gerontology, Family Practice and Toxicology, having authored 29 papers that have together received 3.5k indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (20 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Medication Adherence and Compliance (6 papers). The work is most often cited by research in Geriatrics and Gerontology (2.4k citations), Family Practice (751 citations) and Toxicology (221 citations). Emily Hajjar has collaborated with scholars based in United States. Frequent co-authors include Joseph T. Hanlon, Robert L. Maher, Bhavik M. Shah, Catherine I. Lindblad, Carl F. Pieper, Kenneth E. Schmader, Richard Sloane, Christine M. Ruby, Ginah Nightingale and Kristine Swartz. Their work appears in journals such as Journal of Clinical Oncology, Journal of the American Geriatrics Society and The Journals of Gerontology Series A.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026